Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Keratinocyte gene therapy

J C Vogel1

  • 1Dermatology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md.

Archives of Dermatology
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Keratinocyte gene therapy shows promise for treating genetic diseases by utilizing skin cells to express therapeutic proteins. However, achieving sustained systemic delivery of these factors remains a key challenge for future research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Geographical and environmental distribution of C<sub>3</sub> and C<sub>4</sub> grasses in the Sinai, Negev, and Judean deserts.

Oecologia·2017
Same author

Sporophytic self-incompatibility genes and mating system variation in Arabis alpina.

Annals of botany·2011
Same author

Population structure and historical biogeography of European Arabidopsis lyrata.

Heredity·2010
Same author

Genetic diversity and phylogeography in two diploid ferns, Asplenium fontanum subsp. fontanum and A. petrarchae subsp. bivalens, in the western Mediterranean.

Molecular ecology·2009
Same author

Genetic discontinuity, breeding-system change and population history of Arabis alpina in the Italian Peninsula and adjacent Alps.

Molecular ecology·2008
Same author

Recombination diversifies chloroplast trnF pseudogenes in Arabidopsis lyrata.

Journal of evolutionary biology·2007
Same journal

Scoring With SCORTEN-Reply.

Archives of dermatology·2017
Same journal

Comparison of Early and Late Latent Syphilis- Colorado, 1991.

Archives of dermatology·2016
Same journal

Case of Rhinoscleroma.

Archives of dermatology·2016
Same journal

Cutaneous Fungal Infections.

Archives of dermatology·2016
Same journal

An Ulcerated Plaque in a Gay Man.

Archives of dermatology·2016
Same journal

Solitary Violaceous Nodule on the Face.

Archives of dermatology·2016
See all related articles

Area of Science:

  • Biotechnology
  • Dermatology
  • Genetics

Background:

  • Gene therapy utilizes keratinocytes to express therapeutic genes for treating genetic disorders.
  • Keratinocytes offer potential for treating both systemic and skin-specific genetic diseases.

Purpose of the Study:

  • To evaluate the potential of keratinocytes as a cellular vehicle for gene therapy.
  • To explore the application of keratinocyte gene therapy in treating genetic diseases.

Main Methods:

  • Keratinocytes are engineered to express therapeutic factors like human growth hormone and factor IX.
  • Animal models are used to assess the systemic secretion of factors by engineered keratinocytes.

Main Results:

  • Keratinocytes demonstrate potential for secreting therapeutic factors into the bloodstream in animal models.

Related Experiment Videos

  • Genetic skin diseases like epidermolysis bullosa dystrophica and xeroderma pigmentosum have not yet been targeted by keratinocyte gene therapy in animal models.

    • Conclusions:

    • Keratinocytes possess advantages as a gene therapy target, with progress demonstrated in animal models.
    • Sustained and efficient delivery of therapeutic factors via keratinocyte-expressed transgenes to the bloodstream is yet to be achieved.
    • Future research aims to ensure adequate and prolonged expression of therapeutic factors by keratinocytes for systemic treatment.